Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 22808956 | MHC (MHC) | anca-associated vasculitis | European | NA | NA | unclassified | |
| we found both major-histocompatibility-complex (mhc) and non-mhc associations with anca-associated vasculitis and also that granulomatosis with polyangiitis and microscopic polyangiitis were genetically distinct. | |||||||
| 22808956 | MHC (MHC) | granulomatosis with polyangiitis | European | NA | NA | unclassified | |
| we found both major-histocompatibility-complex (mhc) and non-mhc associations with anca-associated vasculitis and also that granulomatosis with polyangiitis and microscopic polyangiitis were genetically distinct. | |||||||
| 25523449 | NA (NA) | microscopic polyangiitis | NA | NA | NA | unclassified | |
| granulomatosis with polyangiitis (wegener's gpa) with hla-dp1, microscopic polyangiitis with hla-dq and eosinophilic gpa (churg-strauss) with hla-drb4. | |||||||
| 25523449 | NA (NA) | granulomatosis with polyangiitis | NA | NA | NA | unclassified | |
| granulomatosis with polyangiitis (wegener's gpa) with hla-dp1, microscopic polyangiitis with hla-dq and eosinophilic gpa (churg-strauss) with hla-drb4. | |||||||
| 8641024 | HLA-DR (HLA-DR) | ruptures | NA | NA | NA | positive | |
| hla-dr expression was more often seen in macrophages and t cells in ruptures (25 of 28 cases) compared with expression in macrophages in superficial erosion arteries (8 of 22 cases, p = .0002). | |||||||
| 14605498 | HLA MATCHED (HLA-MATCHED) | x-linked adrenoleukodystrophy | NA | NA | NA | positive | |
| we report a 6-year-old male with cerebral x-linked adrenoleukodystrophy who received an hla-matched unrelated bone marrow transplant (bmt). | |||||||
| 29330393 | HLA (HLA) | fludarabine | NA | mycophenolate | NA | unclassified | |
| NA | |||||||
| 31350055 | HLA (HLA) | busulfan | NA | fludarabine | NA | negative | |
| NA | |||||||
| 7488982 | HLA-DR (HLA-DR) | temporomandibular disorders | NA | NA | NA | unclassified | |
| interleukin-6 in synovial fluid and hla-dr expression in synovium from patients with temporomandibular disorders. | |||||||
| 8977634 | HLA-A*02 | prostate cancer | NA | NA | NA | unclassified | |
| phase i clinical trial: t-cell therapy for prostate cancer using autologous dendritic cells pulsed with hla-a0201-specific peptides from prostate-specific membrane antigen. | |||||||
Copyright 2024